Gabriella Rogers from 9NEWS Sydney looks at new biobank, which will help with clinical trials, and talks to Lifehouse patient Narelle Fletcher. Narelle has triple-negative breast cancer. Researchers analysed samples and found that a new immunotherapy drug could be of benefit to patients with triple-negative breast cancer. A new clinical trial at Lifehouse is now focussing on this.
Recent Posts
